Found: 13
Select item for more details and to access through your institution.
Structure–activity trends analysis between amino acid compositions and minimal inhibitory concentrations of antimicrobial peptides.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 438, doi. 10.1111/cbdd.14003
- By:
- Publication type:
- Article
Chalcone‐inspired rA<sub>1</sub>/A<sub>2A</sub> adenosine receptor ligands: Ring closure as an alternative to a reactive substructure.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 416, doi. 10.1111/cbdd.13999
- By:
- Publication type:
- Article
Synthesis and structure–activity relationship of L‐methionine‐coupled 1,3,4‐thiadiazole derivatives with activity against influenza virus.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 398, doi. 10.1111/cbdd.13995
- By:
- Publication type:
- Article
Bioisosteric modification on benzylidene‐carbonyl compounds improved the drug‐likeness and maintained the antifungal activity against Sporothrix brasiliensis.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 391, doi. 10.1111/cbdd.13994
- By:
- Publication type:
- Article
SU5, a new Auraptene analog with improved metabolic stability, ameliorates nonalcoholic fatty liver disease in methionine‐ and choline‐deficient diet‐fed db/db mice.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 504, doi. 10.1111/cbdd.14021
- By:
- Publication type:
- Article
Structure‐based discovery of (S)‐2‐amino‐6‐(4‐fluorobenzyl)‐5,6,11,11a‐tetrahydro‐1H‐imidazo[1′,5′:1,6]pyrido[3,4‐b]indole‐1,3(2H)‐dione as low nanomolar, orally bioavailable autotaxin inhibitor
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 496, doi. 10.1111/cbdd.14017
- By:
- Publication type:
- Article
Discovery of a novel and orally active Farnesoid X receptor agonist for the protection of acetaminophen‐induced hepatotoxicity.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 483, doi. 10.1111/cbdd.14014
- By:
- Publication type:
- Article
Design, synthesis, and molecular modeling of quinoline‐based derivatives as anti‐breast cancer agents targeting EGFR/AKT signaling pathway.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 470, doi. 10.1111/cbdd.14012
- By:
- Publication type:
- Article
Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 456, doi. 10.1111/cbdd.14010
- By:
- Publication type:
- Article
Interleukin‐25 recognition by its unique receptor IL‐17Rb via two discrete linear and cyclic epitopes.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 382, doi. 10.1111/cbdd.13993
- By:
- Publication type:
- Article
Theoretical study of myriocin‐binding mechanism targeting serine palmitoyltransferase.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. 373, doi. 10.1111/cbdd.13991
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. ii, doi. 10.1111/cbdd.13873
- Publication type:
- Article
Cover Image.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 99, n. 3, p. i, doi. 10.1111/cbdd.13872
- Publication type:
- Article